Artal Group’s Atara Biotherapeutics ATRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-40,000	Closed	-$7.79M	–	139
2022 Q2	$7.79M	Hold	40,000	–	–	0.43%	44
2022 Q1	$9.29M	Sell	40,000 -20,000	-33%	-$6.37M	0.39%	51
2021 Q4	$23.6M	Hold	60,000	–	–	0.69%	40
2021 Q3	$26.9M	Hold	60,000	–	–	0.66%	38
2021 Q2	$23.3M	Sell	60,000 -20,000	-25%	-$7.13M	0.53%	46
2021 Q1	$28.7M	Sell	80,000 -32,000	-29%	-$14.1M	0.61%	46
2020 Q4	$55M	Buy	112,000 +22,000	+24%	+$10.2M	1.26%	24
2020 Q3	$29.2M	Sell	90,000 -10,000	-10%	-$3.41M	0.96%	32
2020 Q2	$36.4M	Hold	100,000	–	–	1.24%	24
2020 Q1	$21.3M	Buy	100,000 +30,000	+43%	+$9.52M	1.02%	29
2019 Q4	$28.8M	Buy	70,000 +10,000	+17%	+$3.45M	1.2%	19
2019 Q3	$21.2M	Buy	60,000 +14,000	+30%	+$5.22M	1.03%	20
2019 Q2	$23.1M	Hold	46,000	–	–	1.06%	26
2019 Q1	$45.7M	Buy	46,000 +6,000	+15%	+$5.57M	2.18%	14
2018 Q4	$34.7M	Hold	40,000	–	–	1.73%	18
2018 Q3	$41.4M	Hold	40,000	–	–	1.44%	17
2018 Q2	$36.8M	Sell	40,000 -10,000	-20%	-$10.7M	0.96%	18
2018 Q1	$48.8M	Buy	50,000 +10,000	+25%	+$9.11M	0.72%	17
2017 Q4	$18.1M	Buy	40,000 +16,000	+67%	+$5.91M	0.34%	32
2017 Q3	$9.93M	Buy	24,000 +4,000	+20%	+$1.51M	0.2%	41
2017 Q2	$7M	Hold	20,000	–	–	0.15%	44
2017 Q1	$10.3M	Hold	20,000	–	–	0.26%	39
2016 Q4	$7.1M	Buy	20,000 +11,000	+122%	+$4.66M	0.19%	46
2016 Q3	$4.81M	Buy	+9,000	New	+$4.89M	0.12%	59

Other funds holding ATRA